Tortoise Capital Advisors L.L.C. Sells 1,750 Shares of Xylem Inc. (NYSE:XYL)

Tortoise Capital Advisors L.L.C. cut its position in Xylem Inc. (NYSE:XYL) by 10.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 15,805 shares of the industrial products company’s stock after selling 1,750 shares during the period. Tortoise Capital Advisors L.L.C.’s holdings in Xylem were worth $1,662,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Cookson Peirce & Co. Inc. bought a new stake in Xylem in the 1st quarter valued at $4,205,000. Teacher Retirement System of Texas boosted its stake in Xylem by 22.4% in the 1st quarter. Teacher Retirement System of Texas now owns 20,152 shares of the industrial products company’s stock valued at $2,120,000 after purchasing an additional 3,683 shares during the period. Alliancebernstein L.P. raised its holdings in Xylem by 18.3% in the 1st quarter. Alliancebernstein L.P. now owns 2,634,838 shares of the industrial products company’s stock valued at $277,132,000 after acquiring an additional 407,211 shares in the last quarter. Smith Salley & Associates raised its holdings in Xylem by 5.7% in the 1st quarter. Smith Salley & Associates now owns 114,782 shares of the industrial products company’s stock valued at $12,073,000 after acquiring an additional 6,232 shares in the last quarter. Finally, M&T Bank Corp raised its holdings in Xylem by 4.6% in the 1st quarter. M&T Bank Corp now owns 150,061 shares of the industrial products company’s stock valued at $15,783,000 after acquiring an additional 6,583 shares in the last quarter. Institutional investors and hedge funds own 83.20% of the company’s stock.

In other Xylem news, SVP Colin R. Sabol sold 5,593 shares of the company’s stock in a transaction dated Friday, May 7th. The stock was sold at an average price of $118.81, for a total value of $664,504.33. Following the sale, the senior vice president now owns 32,268 shares in the company, valued at approximately $3,833,761.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Hayati Yarkadas sold 611 shares of the company’s stock in a transaction dated Wednesday, May 12th. The shares were sold at an average price of $117.10, for a total value of $71,548.10. Following the completion of the sale, the senior vice president now owns 8,369 shares in the company, valued at approximately $980,009.90. The disclosure for this sale can be found here. Insiders have sold a total of 29,249 shares of company stock worth $3,491,860 in the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Several equities analysts have weighed in on the company. Credit Suisse Group lifted their price objective on Xylem from $90.00 to $97.00 and gave the company an “underperform” rating in a report on Wednesday, May 5th. The Goldman Sachs Group raised Xylem from a “sell” rating to a “neutral” rating and lifted their price objective for the company from $73.00 to $107.00 in a report on Wednesday, May 5th. Morgan Stanley assumed coverage on Xylem in a report on Wednesday, March 31st. They issued an “overweight” rating and a $120.00 price objective for the company. Zacks Investment Research raised Xylem from a “sell” rating to a “hold” rating and set a $123.00 price objective for the company in a report on Thursday, May 6th. Finally, Royal Bank of Canada boosted their price target on Xylem from $112.00 to $127.00 and gave the stock an “outperform” rating in a report on Wednesday, May 5th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $103.17.

XYL stock traded down $0.41 during midday trading on Thursday, reaching $122.02. 5,162 shares of the stock were exchanged, compared to its average volume of 896,025. The company has a market cap of $21.97 billion, a PE ratio of 73.31, a PEG ratio of 3.67 and a beta of 1.02. Xylem Inc. has a 52 week low of $71.87 and a 52 week high of $121.97. The company has a quick ratio of 1.52, a current ratio of 1.84 and a debt-to-equity ratio of 0.84. The firm has a fifty day moving average of $118.17.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, May 4th. The industrial products company reported $0.56 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.19. The business had revenue of $1.26 billion for the quarter, compared to analyst estimates of $1.17 billion. Xylem had a return on equity of 14.89% and a net margin of 6.05%. Xylem’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.23 EPS. As a group, sell-side analysts expect that Xylem Inc. will post 2.76 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 24th. Investors of record on Thursday, May 27th were given a dividend of $0.28 per share. The ex-dividend date was Wednesday, May 26th. This represents a $1.12 dividend on an annualized basis and a yield of 0.92%. Xylem’s dividend payout ratio is currently 54.37%.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.

Featured Article: Hedge Funds Explained

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.